Back to top

Image: Bigstock

Top Ranked Income Stocks to Buy for January 20th

Read MoreHide Full Article

Here are three stocks with buy rank and strong income characteristics for investors to consider today, January 20th:

Moelis & Company (MC - Free Report) : This provider of strategic and financial advisory services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 51% over the last 60 days.

Moelis & Company Price and Consensus

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.78%, compared with the industry average of 0.00%. Its five-year average dividend yield is 4.35%.

Moelis & Company Dividend Yield (TTM)

Norbord Inc. : This manufacturer of wood-based panels, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days.

Norbord Inc. Price and Consensus

This Zacks Rank #1 company has a dividend yield of 4.59%, compared with the industry average of 0.41%. Its five-year average dividend yield is 5.4%.

Norbord Inc. Dividend Yield (TTM)

Rio Tinto Group (RIO - Free Report) : This company that engages in finding, mining, and processing mineral resources has witnessed the Zacks Consensus Estimate for its current year earnings increasing 47.3% over the last 60 days.

Rio Tinto PLC Price and Consensus

This Zacks Rank #1 company has a dividend yield of 3.80%, compared with the industry average of 0.00%. Its five-year average dividend yield is 6.29%.

Rio Tinto PLC Dividend Yield (TTM)

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Rio Tinto PLC (RIO) - free report >>

Moelis & Company (MC) - free report >>